KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Kiniksa Pharmaceuticals International, plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$79.48+0.89 (+1.13%)
Close on Oct 19, 2026
- Market cap
- $6.63B
- P/E (TTM)
- 81.9
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$677.56MFY2025, +104.8% a year since FY2021